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Abstract
Background: Effective interventions to reduce mortality and morbidity in maternal and newborn health already
exist. Information about quality and performance of care and the use of critical interventions are useful for shaping
improvements in health care and strengthening the contribution of health systems towards the Millennium
Development Goals 4 and 5. The near-miss concept and the criterion-based clinical audit are proposed as useful
approaches for obtaining such information in maternal and newborn health care. This paper presents the methods
of the World Health Organization Multicountry Study in Maternal and Newborn Health. The main objectives of this
study are to determine the prevalence of maternal near-miss cases in a worldwide network of health facilities,
evaluate the quality of care using the maternal near-miss concept and the criterion-based clinical audit, and
develop the near-miss concept in neonatal health.
Methods/Design: This is a large cross-sectional study being implemented in a worldwide network of health
facilities. A total of 370 health facilities from 29 countries will take part in this study and produce nearly 275,000
observations. All women giving birth, all maternal near-miss cases regardless of the gestational age and delivery
status and all maternal deaths during the study period comprise the study population. In each health facility,
medical records of all eligible women will be reviewed during a data collection period that ranges from two to
three months according to the annual number of deliveries.
Discussion: Implementing the systematic identification of near-miss cases, mapping the use of critical evidence-
based interventions and analysing the corresponding indicators are just the initial steps for using the maternal
near-miss concept as a tool to improve maternal and newborn health. The findings of projects using approaches
similar to those described in this manuscript will be a good starter for a more comprehensive dialogue with
governments, professionals and civil societies, health systems or facilities for promoting best practices, improving
quality of care and achieving better health for mothers and children.
Background
Nearly 1,000 women die every day and ten million
women present with complications related to pregnancy
every year around the world [1]. Haemorrhage, infec-
tion, hypertensive disorders, obstructed labour and com-
plications of unsafe abortion are the main pregnancy
related complications that threaten women’s life [2]. In
addition, three million neonatal deaths, representing
about 40% of all under-five infant mortality occur every
year [3]. Three quarters of these neonatal deaths occur
in the first week of life. Preterm birth, infections, and
asphyxia are the major direct causes of neonatal deaths
[4]. The vast majority of these deaths occur in develop-
ing countries and this burden motivated world leaders
to formulate the millennium declaration, which has as
outstanding targets the reduction of maternal and infant
mortality in global scale. In September 2010, the United
Nations Secretary-General launched the Global Strategy
for Women’s and Children’s Health calling for concrete
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actions towards the improvement of health of women
and children around the world [5].
Unfortunately, many of the complications leading to
severe morbidity and deaths of mothers and newborns
are not easily prevented. Several factors (individual,
social, societal, health-system related etc) aggravate the
vulnerability of mothers and children to complications
and deaths related to pregnancy and childbirth. How-
ever, timely and optimal treatment can largely improve
survival [6,7]. The evidence shows that high maternal,
perinatal, neonatal and child mortality rates are asso-
ciated with inadequate and poor quality health services.
Evidence also suggests that explicit, evidence-based, cost
effective packages of interventions can improve the pro-
cesses and outcomes of health care when appropriately
implemented. The interventions for life support and
emergency obstetric care include the administration of
parenteral antibiotics, uterotonic drugs, anticonvulsants,
manual removal of placenta, removal of retained pro-
ducts of conception, assisted vaginal delivery, obstetric
surgery (caesarean section and hysterectomy), safe blood
transfusion, resuscitation of the newborn and corticos-
teroids during preterm labour which can reduce mater-
nal and newborn mortality [6,8]. Complications not
recognized in a timely manner or not treated appropri-
ately are likely to progress to organ dysfunction and
deaths. Furthermore, even despite appropriate initial
care, some women and newborn may develop organ
dysfunctions which constitute a common final pathway
towards death [9,10]. At this stage, more specialized and
expensive interventions would be necessary to revert
life-threatening conditions related to pregnancy and
childbirth. In this continuum, the timing and appropri-
ateness of care can explain part of the huge difference
observed between developed and developing countries
in terms of maternal and infant mortality.
Auditing deaths is an approach commonly used for
assessing the quality of care and identifying opportu-
nities for improvement [11]. Women who survive life-
threatening conditions arising from complications
related to pregnancy and childbirth have many common
aspects with those who die of such complications. This
similarity led to the development of the near-miss con-
cept in maternal health. Exploring the similarities, the
differences and the relationship between women who
died and those who survived life-threatening conditions
provide a more complete assessment of quality in
maternal health care [12-15].
The WHO approach to the near-miss concept in maternal
and newborn health
A systematic review on the prevalence of severe acute
maternal morbidity and maternal near-miss was con-
ducted by the WHO in 2004 [12]. This systematic
review found a wide variation of criteria used to identify
near-miss cases. Owing to the variations in the identifi-
cation criteria, the corresponding severity of the “near-
miss” cases identified by different authors was too het-
erogeneous and a summary estimate for maternal near-
miss prevalence was not feasible. In 2007, WHO estab-
lished a technical working group of obstetricians, mid-
wives, epidemiologists and public health professionals
from developing and developed countries to produce a
standard definition and uniform identification criteria
for maternal near-miss cases. Aiming to achieve a rea-
sonable balance between the burden of data collection
and useful information, this working group targeted the
identification of very severe cases, essentially those pre-
senting with features of organ dysfunctions. A standard
definition has been developed, tested and validated.
Detailed information about the near-miss concept and
its development is published elsewhere [16]. The mater-
nal near-miss concept was suggested to be routinely
used in national programmes as tool for evaluating the
quality of maternal health care [17].
In addition, indicators attached to the near-miss con-
cept were developed for the assessment of quality of
care. The near-miss indicators are indicators of outcome
and provide an overall evaluation of the performance of
the health service or health system in reducing severe
maternal short-term outcomes [16]. In order to produce
a more complete and even more tangible evaluation of
quality of care, a set of process indicators was adapted
and developed based on the criterion-based clinical
audit (CBCA) concept. CBCA is considered a feasible
and beneficial mode of auditing the quality of maternal
health care [18]. These process indicators assess the use
of priority effective interventions in the prevention and
management of severe complications related to preg-
nancy and childbirth and can be tailored according to
local standards of care.
Similar to the maternal near-miss approach, neonates
that nearly died but survived severe complications at
birth or during the neonatal period (e.g. infants who
survived extreme preterm birth, very low birth weight,
birth asphyxia, birth trauma, neonatal sepsis) could be
studied as surrogates of neonatal deaths [19]. There is
currently no standard definition for neonatal near miss.
In this context, a newborn that requires a life-saving
intervention (e.g. intubation) and did not receive it will
very likely die. Thus, life-saving interventions could be
an entry point to initiate the development of the neona-
tal near-miss definition, together with other indicators
of increased risk of death [20]. Near-miss indicators,
similar to those established in the maternal near-miss
context, could be used to explore this new field and
assess the quality of care provided to newborns with
severe complications [19,20].
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In summary, effective interventions to reduce mortal-
ity and morbidity in maternal and newborn health
already exist and many of these interventions should be
put in practice at health facilities [6,7]. Information
about quality and performance of care and the use of
critical interventions would be useful for shaping
improvements in health care and strengthening the con-
tribution of health systems towards the Millennium
Development Goals 4 and 5 [21]. The near-miss concept
and the criterion-based clinical audit are proposed as
useful approaches for obtaining such information in
maternal and newborn health care.
Objectives
In this paper, we present the methods of the World Health
Organization Multicountry Survey on Maternal and New-
born Health. The main objectives of this study are to
determine the prevalence of maternal near-miss cases in a
worldwide network of health facilities, evaluate the quality
of care using the maternal near-miss concept and the cri-
terion-based clinical audit, and explore the use of the
near-miss concept in perinatal health. As this study fol-
lows the WHO Global Survey on Maternal and Perinatal
Health and maintains key methodological features of that
study, we also highlight some of their differences.
Methods/Design
Research design and cluster selection
This is a cross-sectional study which will be implemen-
ted in the network of health facilities that participated
in the previous WHO Global Survey on Maternal and
Perinatal Health. These facilities were identified through
a multi-stage sampling method [22]. The first stage of
sampling was the selection of countries. This selection
was stratified according to the WHO regions and the
levels of under-five child and adult mortality. Fourteen
sub-regions constituted the sampling frame for the first
stage of selection. From each sub-region, a total of four
countries were selected at random for participation in
the study, with probability proportional to the country
population. When the total number of countries was
less than four in any sub-region, all the countries were
included. This process resulted in 12 sub-regions having
four countries each and two sub-regions having three
countries each. A total of 54 countries were initially
pre-selected, but, due to operational and budgetary rea-
sons, the WHO Global Survey project was implemented
in 24 countries from Africa, Asia and Latin America.
The second stage of sampling consisted of random
selection of two provinces/states (with probability also
proportional to the population size), in addition to the
capital city in these 24 countries. A third sampling stage
(also based on the population size but reaching sub-divi-
sions below the province/state level) was used for very
large provinces/states. For very large cities (e.g. Mexico
City and Beijing), a fourth sampling stage was imple-
mented based on the random selection of city geogra-
phical sub-divisions, with probability proportional to
city sub-division population. Once the geographical
areas were selected, seven health facilities with a mini-
mum of 1,000 deliveries per year were randomly
selected from each of these areas with probability pro-
portional to the annual number of deliveries. If there
were less than 7 facilities, all facilities in that area were
selected. In the end, the WHO Global Survey Project
showed that such a sampling scheme was feasible and
could represent the facility-based health care systems
available in the countries (private, social service, public,
etc) [22]. For the present study, the existing network of
health facilities has undergone adjustments considering
logistic factors, resource issues, and the availability and
motivation of collaborating facilities. Afghanistan and
Pakistan, countries that were previously selected to par-
ticipate in the Global Survey project, have been included
in the multicountry survey and the selection of health
facilities has followed the previously used random sam-
pling scheme. Mongolian health facilities were also
added to the network using the same procedures. In
addition, selected facilities from Jordan, Lebanon, Pales-
tine (West Bank) and Qatar were added to the network.
The health facilities from Cuba, Algeria and the Mexi-
can State of Tamaulipas were discontinued. In the end,
370 health facilities from 29 countries (i.e. Afghanistan,
Angola, Argentina, Brazil, Cambodia, China, Democratic
Republic of the Congo, Ecuador, India, Japan, Jordan,
Kenya, Lebanon, Mexico, Mongolia, Nepal, Nicaragua,
Niger, Nigeria, Pakistan, Palestine, Paraguay, Peru, Phi-
lippines, Qatar, Sri Lanka, Thailand, Uganda, Viet Nam)
will participate in this study.
Study participants
During the data collection period, each health facility
will include all eligible participants. The eligible partici-
pants are:
• all women giving birth during the data collection
period in the participating hospitals together with
their respective newborns;
• all maternal near-miss cases admitted in the parti-
cipating hospitals up to seven postpartum/postabor-
tion days, regardless of the gestational age and
delivery status;
• all maternal deaths taking place in the participating
hospitals up to seven postpartum/postabortion days,
regardless of the gestational age and delivery status.
The WHO criteria will be used to identify maternal
near-miss cases (Table 1). Participants will be excluded
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if they were admitted to the participating hospitals after
seven days of termination of pregnancy (delivery or
abortion).
Data collection and data management
This study will collect data at two levels, the individual
and the facility level. At the individual level, the study
participants (and their respective newborns) will have
their medical records reviewed, whereas at the facility
level, data will be collected through a specific survey
among the professionals responsible for the participating
facilities.
Study variables are described in detail in the study
protocol and manual of operations. In brief, at the indi-
vidual level, these variables include maternal and new-
born individual data, data related to the pregnancy
outcomes, severe complications and their management.
At the facility level, the characteristics of each health
facility and their ability to identify and manage severe
complications will be investigated.
At the individual level, in each health facility, data col-
lectors will perform daily visits to the obstetrical/post-
partum ward, gynaecologic/abortion care unit, delivery
room and intensive care unit to identify women with
life-threatening conditions. Upon discharge from hospi-
tal or in the event of maternal death, the study partici-
pants will have their medical records reviewed. The
facility medical staff will be questioned for doubts dur-
ing data collection or missing information.
In general, the duration of data collection will be two
months if the health facility had 6,000 deliveries/year or
more (in the year that preceded the study implementa-
tion) and three months if the health facility had less
than 6,000 deliveries/year. In Jordan, Lebanon, Palestine
(West Bank) and Qatar, the data collection period will
be extended to four months in all health facilities con-
sidering the number and characteristics of health facil-
ities in order to obtain meaningful data. There will be
no individual follow-up of women or newborns after
hospital discharge. Data will be collected only from the
hospital medical records with regards to the intra-hospi-
tal care up to the seventh day following delivery or
abortion. With this sampling scheme, the expected sam-
ple size will be around 275,000 women.
The individual level and the cluster level data will be
initially collected on paper forms. Then, data will be
entered onto a web-based data management system
developed by the Centro Rosarino de Estudios
Table 1 The WHO maternal near-miss criteria*
Identification criteria
Cardiovascular dysfunction • Shock
• Use of continuous vasoactive drugs
• Cardiac arrest
• Cardio-pulmonary resuscitation
• Severe hypoperfusion (lactate > 5 mmol/L or > 45 mg/dL)
• Severe acidosis (pH < 7.1)
Respiratory dysfunction • Acute cyanosis
• Gasping
• Severe tachypnea (respiratory rate > 40 bpm)
• Severe bradypnea (respiratory rate < 6 bpm)
• Severe hypoxemia (PAO2/FiO2 < 200 or O2 saturation < 90% for ≥60 min)
• Intubation and ventilation not related to anaesthesia
Renal dysfunction • Oliguria non responsive to fluids/diuretics
• Dialysis for acute renal failure
• Severe acute azotemia (creatinine ≥ 300 umol/ml or ≥ 3.5 mg/dL)
Coagulation/hematologic dysfunction • Failure to form clots
• Massive transfusion of blood or red cells (≥ 5 units)
• Severe acute thrombocytopenia (< 50,000 platelets/ml)
Hepatic dysfunction • Jaundice in the presence of pre-eclampsia
• Severe acute hyperbilirubinemia (bilirubin > 100 umol/L or > 6.0 mg/dL)
Neurologic dysfunction • Prolonged unconsciousness (lasting ≥ 12 hours)/coma (including metabolic coma)
• Stroke
• Status epilepticus/uncontrollable fits
• Total paralysis
Uterine dysfunction • Haemorrhage or infection leading to hysterectomy
* Detailed information available at references [16] and [24]
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Perinatales (CREP, Rosario, Argentina). This software
was designed according to the main standards defined
by the United States Food and Drug Administration
[23]. The WHO Coordinating Unit and the centres will
decide whether online data entry will take place at the
facility or at a more central level depending on the
resources available in each centre. Regional data man-
agers will monitor the data flow and its quality using
data validation and progress reports that are automati-
cally generated by the web-based system. These proce-
dures have been used in previous multicentre studies,
including the WHO Global Survey on Maternal and
Perinatal Health [22].
Quality control procedures
The majority of the facilities have participated in the
previous WHO Global Survey on Maternal and New-
born Health and the data collectors and their supervi-
sors are conversant with the data collection and entry
methods. Training will be emphasized in those facilities
that are new in the network. Online data entry system
will minimize the data entry errors and facilitate moni-
toring and quick resolution of queries and missing data.
Data inconsistencies will be identified and corrected as
they occur, using specific reports included in the web-
based data management system and parallel arrange-
ments, in order to obtain a clean database soon after
the end of data collection in each site. A manual of
operations has been developed to minimize the need for
judgement and interpretation by the data collectors. The
manual of operations includes a description of the study
in general terms, emphasizes the importance of com-
plete and accurate data, and fosters the standardization
of data collection. The data collection tools have been
reviewed by other researchers and pre-tested on a con-
venient sample of records and clinical settings. Training
workshops at country and facility levels will be carried
out and tailored according to specific needs. In each
country, a pilot phase will be implemented in order to
test the complete data management process (data collec-
tion, data entry and query procedures). The total num-
ber of women delivering at the facilities during data
collection will be independently monitored and these
numbers will be compared to those determined by the
data collection. Intra-form validity cross-checks will be
performed in addition to random cross-checks compar-
ing medical records against form and electronic data.
The staff responsible for data will maintain a log book
to document unanticipated problems. Technical ques-
tions encountered in the field will be resolved through
consultation with the country and regional coordinators
under the supervision of the WHO coordinating unit.
Missing data in medical records will be obtained from
the attending physician.
Ethical considerations
This is an observational study, in which data will be col-
lected and extracted from the health facility medical
records without any identification of the study partici-
pant. Data will be extracted anonymously from hospital
records with no personal identifiers and reported cumu-
latively. Information will not be obtained directly from
the study participants, nor will participant interviews
take place. The facility medical staff may be asked to
clarify doubtful or missing information during data col-
lection. Information on the participating subject (i.e.
name, individual identification code at the hospital,
birth date and delivery date) will be kept in the log
book at the institutional level (by a person in charge of
data collection) to help completeness of the form in
case significant details are missed from being recorded
or if the queries are raised at the data cleaning stage.
Data collectors and other study staff will ensure the
confidentiality of logbooks and other data storage
devices (e.g. computers) by ensuring that logbooks are
not taken out of the hospital premises, keeping them in
locked lockers, password secured databases and secure
removal of computer data/shredding of any study log-
books at completion of central database cleaning. There-
fore, individual informed consent from the individual
study participants is not necessary.
Data collectors will be selected among the health facil-
ity staff. If additional study staff is employed (i.e. not a
staff of that specific health facility) to extract data from
facility records, the additional staff will sign a confiden-
tiality agreement and report to the facility management
and the study investigators. Thus, the additional study
staff will be governed by the same rules in relation to
confidentiality and legal indemnity that will also govern
the conduct of hospital staff. In any case, as a facility
based study, an authorization to perform the study will
be obtained at the institutional level from the responsi-
ble authority (director or medical chief) in all selected
health facilities. At any country or health facility in
which this study is to be implemented the relevant ethi-
cal clearance should be obtained. This study protocol
has been approved by the World Health Organization
Ethical Review Committee.
Project implementation and management
This project is a complex operation involving many peo-
ple at facility, country, continental and global levels. The
overall coordination of the project is carried out by the
global coordinating unit at the WHO Department of
Reproductive Health and Research in Geneva, Switzer-
land. There are regional coordinators for Africa, Ameri-
cas and Asia. The regional coordination for Afghanistan
and Pakistan will be provided by the regional coordina-
tor of Asia. Each country will have a country
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coordinator. The country coordinator will be responsible
for coordinating data collection from all the selected
health facilities within that country. Due to practical
reasons, coordination for Jordan, Palestine and Qatar
will be provided by the Lebanon country coordinator,
who will liaise directly with the global coordination.
There will be one coordinator from each selected health
facility. The health facility coordinator will be assisted
by a data collector/s who will be responsible for the day
to day collection of the data from the records and a
data clerk/s who will assist in online data entry. Despite
being one single project involving 29 countries, in prac-
tice, this project functions as a coordinated set of 29
studies using the same research protocol in 29 coun-
tries. Data collection started in May 2010 and will be
finalized in all countries by the end of 2011.
Analysis plan
At country level and for every country, a descriptive
analysis will be carried out with emphasis on the mater-
nal near-miss indicators and the criterion-based clinical
audit process indicators.
At the global level, two main analyses are anticipated,
one focused on maternal health, using the maternal
near-miss approach, and other focused on newborn
health. The resulting estimates will always refer to the
facility-based sample. Analysis techniques for a stratified
multi-level sampling design will be used to obtain
descriptive data including worldwide, regional, and
country estimates of prevalence of severe maternal com-
plications (i.e. causes and other conditions associated to
maternal deaths and maternal near-miss cases), maternal
near miss, and neonatal conditions. The associations
between the use of interventions and the maternal and
perinatal outcome will be examined. The proportions
between maternal complications, maternal near miss
and maternal deaths will be used to assess the quality of
care. All analyses will consider the influence of potential
confounding variables. Multilevel modelling will be
used, which offers the flexibility of simultaneously con-
trolling for confounding variables while estimating the
prevalence of outcomes and the assessment of interac-
tion. Multiple logistic regressions adjusted for clustering
will be explored.
The general analytical approach for the main objec-
tives follows:
• The prevalence of maternal near miss will be
determined. The overall estimates with 95% confi-
dence interval will be calculated. The proportions of
women with maternal complications, maternal near
miss and maternal deaths will be assessed.
• Descriptive frequencies of the use of interventions
will be calculated (e.g. use of prophylactic and
therapeutic uterotonics, use of parenteral anticonvul-
sants for eclampsia, ICU admission for life-threaten-
ing conditions etc). The relationship between the
use of these interventions and the maternal and peri-
natal outcome will be evaluated by calculating odds
ratio (crude and adjusted), with 95% confidence
intervals.
• A set of process indicators have been developed
according to pre-defined algorithms. Essentially, we
will evaluate the proportion of women who did
receive a specific intervention compared to the
population that should have received the specific
intervention (for instance, the total number of
women with eclampsia that received magnesium sul-
phate compared to the total number of women with
eclampsia). This approach may indicate gaps in the
implementation of evidence-based practices. Country
and overall estimates will be calculated. This infor-
mation will be related to the best estimate of effect
available for each selected intervention and the
avoidable burden of the complication will be
estimated.
• Markers of severity will be studied as potential cri-
teria for identifying neonatal near-miss cases (Table
2). Neonatal near-miss indicators, similar to those
established in the maternal near-miss context, will
also be used to explore this objective. Individual and
cluster level analyses are expected, evaluating, for
instance, the relationship between availability of life-
saving interventions and the neonatal outcome.
Several other secondary analysis exploring different
aspects of the global database are expected, including
comparisons with the previous WHO Global Survey on
Maternal and Perinatal Health database.
Discussion
This paper outlines the study protocol for a large World
Health Organization multinational study using the
maternal near-miss concept and a criterion-based clini-
cal audit approach. This protocol has been developed
through a consultative process involving a large number
of stakeholders from several countries. In addition to
the WHO study, a number of other studies are imple-
menting this protocol with minor adaptations. Combin-
ing the expected number of participants in our study
with those of other initiatives that we are aware of, over
one million women, from at least 800 health facilities
around the world will be included in studies using
research protocols based on the original protocol out-
lined in this paper. Thus, this study protocol will be the
basis for obtaining important evidence about the use of
the near-miss concept in maternal and newborn health.
In addition to the information on the prevalence of
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Table 2 Conditions to be tested as criteria for identifying neonatal near-miss cases
Identification criteria
Clinical organ dysfunction • Respiratory rate > 100 breaths per minute
• Cyanosis in room air
• Absence of regular breathing pattern (gasping respiration or frequent
apnoea)
• Cardiac arrest
• Persistent bradycardia < 80 bpm
• Persistent tachycardia > 200 bpm
• Poor capillary filling (> 5s)
• Subaponeurotic haemorrhage
• Seizures
• Severe neurological depression (inability to suck)
• Severe pallor
• Visible jaundice in first 24 hours
• Any active, non traumatic, bleeding (e.g. GI bleeding, pulmonary
haemorrhage)
• Visible haematuria
• Anuria > 24 hours
• Apathetic/Poor tolerance of feeds
• Abdominal distension and vomiting
• Brachial plexus injury
• Skull fracture
Laboratory markers of organ dysfunction • Saturation by pulse oximetry < 85% in room air
• pCO2 > 65 mmHg
• Serum pH < 7.1
• Haematocrit < 30%
• Haemoglobin < 10 g/dl
• Glucose < 30 mg/dl or < 1.7 mmol/l
• White cell count < 4000 cells/mm3
• Neutropaenia < 1000 cells/mm3
• Raised C-Reactive Protein within 48 hours > 10 mg/dlx.
• X-ray signs of intestinal obstruction/perforation
• X-ray signs of skull fracture




• Cardio-pulmonary resuscitation (cardiac massage)
• Use of any vasoactive drug
• Volume expansion
• Use of anticonvulsants
• Use of phototherapy in the first 24 hours
• Exchange transfusion
• Use of any blood products
• Use of steroids to treat refractory hypoglycaemia
• Use of therapeutic IV antibiotics
• Any surgery requiring general anaesthesia
Other conditions highly associated with severity in perinatal
health
• Birth weight < 1500 g
• Gestational age at birth < 31 weeks
• Apgar score 5 minutes < 5
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complications, it will ascertain whether markers of
severe maternal morbidity can be incorporated into rou-
tine data collection systems, and provide a standardized
evaluation of quality of care in a large number of health
facilities in different geographical regions. In the end,
this study will provide a comprehensive evaluation of
the implementation status of critical life-saving interven-
tions in the continuum of maternal and perinatal care.
However, the implementation of this study protocol
may face some challenges. The first one is that the
maternal near-miss concept is relatively new and the
criteria used to identify maternal near-miss cases are
based on organ dysfunction markers. These markers are
not part of the traditional, routinely collected informa-
tion in maternal health. Raising awareness among the
health care professionals who work in the participating
health facilities and motivating them to contribute to
the systematic identification of near-miss cases are
essential components of projects based on this protocol.
Another relevant issue is the fact that this study is facil-
ity-based. Our network is mostly composed of medium
and large facilities, many of them functioning as referral
hospitals in their geographical areas. This may introduce
a bias, overestimating the prevalence of severe complica-
tions. The results will be applicable to facility-based set-
tings, a fact especially relevant for countries with low
health-facility coverage. Given the data collection chal-
lenges involved in conducting a large multi-hospital,
multi-country study, and, in order to keep the data col-
lection burden to a minimum, we have chosen to mea-
sure only short-term, intra-hospital maternal and
perinatal morbidity and mortality. Thus, medium and
long-term maternal and perinatal outcomes of poten-
tially serious consequence are not covered by this study.
In order to further facilitate the use of the methods of
the WHO Multicountry Survey on Maternal and New-
born Health, we developed a study protocol derivative
that complements the previously published papers about
the maternal near-miss definition and criteria. The gen-
eric guide for implementing the WHO near-miss
approach in maternal health services has been prepared
as a simplified version of this protocol and discusses
alternatives to some of the methods used in our study
[24].
Investigators using this study protocol or its deriva-
tives are encouraged to report and publish their find-
ings. We anticipate conducting a systematic review and
meta-analysis of studies that used the WHO criteria for
maternal near miss or developing a repository to accom-
modate those studies and results. Thus, we propose that
authors of studies using the WHO maternal near-miss
criteria report a minimum set of information. This
would include a description of the setting where the
near-miss approach was implemented, the study
eligibility criteria, the period of data collection, the pro-
cedure for case identification, crude value of variables
necessary to calculate the near-miss indicators (i.e. the
total number of live births in the source population, the
number of maternal deaths and the number of near-
miss cases), and an interpretation of the findings consid-
ering the local context. We also suggest that the term
“maternal near miss” is included as a key word for con-
venient indexation and facilitation of retrieval of publi-
cations for future systematic review and meta-analyses.
Conclusion
Implementing the systematic identification of near-miss
cases, mapping the use of evidence-based critical inter-
ventions and analysing the corresponding indicators are
just the initial steps for using the maternal near-miss
concept as a tool to improve maternal and newborn
health. Tailored multifaceted approaches, possibly
including the use of evidence-based guidelines and
reminders, engagement of opinion leaders, and contin-
ued audit and feedback may be needed in selected areas
[24,25]. Ultimately findings of projects using approaches
similar to those described in this paper need to be put
in action. These findings will be a good starter for a
more comprehensive dialogue with policy makers, pro-
fessional and civil societies, health systems or health ser-
vices administrators for promoting best practices,
improving quality of care and achieving better health for
mothers and children.
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